Platform
Home
Screener
Copilot
AskEdgar Studio
New
Back
Longeveron Inc.
LGVN · SEC Filings
website
38
Longeveron Inc. is a biotechnology company currently in the clinical development stage, dedicated to...
Price
2.01
Market Cap
6.11 M
Float
2.59 M
Country
US
Sector
Healthcare
Exchange
NASDAQ
Overview
Filings
Insights
Dilution
News
Transcripts
Search in Documents
Open in Studio
Studio
Login
Ask about LGVN
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
All
Chronological
Financials
Registrations
Prospectus
News
Proxies
Ownerships
Other
Longeveron Inc.
LGVN · SEC Filings
2.59 M
Float
2.01
Price
6.11 M
Market Cap
Financials
TYPE
HEADLINE
FILED AT
News
TYPE
HEADLINE
FILED AT
Prospectus
TYPE
HEADLINE
FILED AT
Registrations
TYPE
HEADLINE
FILED AT
Proxies
TYPE
HEADLINE
FILED AT
Ownerships
TYPE
HEADLINE
FILED AT
Chronological
TYPE
HEADLINE
FILED AT
Other
TYPE
HEADLINE
FILED AT
EFFECT
Form EFFECT - Notice of Effectiveness
Apr 20, 2026
CORRESP
Form CORRESP - Correspondence
Apr 15, 2026
LETTER
Form UPLOAD - SEC-generated letter
Apr 14, 2026
EFFECT
Form EFFECT - Notice of Effectiveness
Aug 11, 2025
CORRESP
Form CORRESP - Correspondence
Aug 8, 2025
CORRESP
Form CORRESP - Correspondence
Aug 8, 2025
